Allarity Therapeutics Inc. (NASDAQ: ALLR) announced its active pharmaceutical ingredient manufacturing campaign for stenoparib is proceeding according to schedule for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA